Polar Asset Management Partners’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$92.7K Hold
1,544,300
– – ﹤0.01% 832
2026
Q2
$124K Buy
1,544,300
+44,300
+3% +$3.79K ﹤0.01% 659
2026
Q1
$120K Hold
1,500,000
– – ﹤0.01% 505
2025
Q4
$210K Buy
+1,500,000
New +$214K ﹤0.01% 504

Other funds holding DMIIR

Polar Asset Management Partners's DMIIR Position: Q3 2026 in Review

Polar Asset Management Partners held its Drugs Made In America Acquisition II Corp Right (DMIIR) position steady in Q3 2026 at 1,544,300 shares worth $92.7K. The position accounts for ﹤0.01% of the portfolio, ranked #832.

Polar Asset Management Partners first reported a position in DMIIR in Q4 2025 and has held it in 4 quarters since. The position peaked at $210K in Q4 2025. 64 funds tracked by Wall St. Rank hold DMIIR as of Q3 2026.

  • Polar Asset Management Partners held 1,544,300 shares of Drugs Made In America Acquisition II Corp Right worth $92.7K as of Q3 2026.
  • Polar Asset Management Partners left its Drugs Made In America Acquisition II Corp Right share count unchanged in Q3 2026.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Polar Asset Management Partners's portfolio in Q3 2026, its #832 holding.
  • Polar Asset Management Partners first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 4 quarters since.
  • Polar Asset Management Partners's Drugs Made In America Acquisition II Corp Right position peaked at $210K in Q4 2025.
  • 64 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q3 2026.

Based on Polar Asset Management Partners's 13F filing for Q3 2026, filed 16 Nov 2026.